Identification of a calcitriol-regulated Sp-1 site in the promoter of human CD14 using a combined western blotting elect rophoresis mobility shift assay (WEMSA)
Open Access
- 1 December 2008
- journal article
- Published by Springer Science and Business Media LLC in Biological Procedures Online
- Vol. 10 (1), 29-35
- https://doi.org/10.1251/bpo140
Abstract
Calcitriol (1α, 25-dihydroxyvitamin D3) induces the expression of CD14 in mononuclear phagocytes. The mechanisms accounting for this have been unclear since the promoter of CD14 does not contain a canonical vitamin D response element (VDRE). Calcitriol has been shown to regulate the activity of the transcription factor Sp-1 and our analysis of the proximal promoter of CD14 indicated the presence of four Sp-1-like binding sequences. To identify which of these sites might be involved in the response to calcitriol, we used a system incorporating an electrophoretic mobility shift assay (EMSA) coupled to Western blot analysis (WEMSA). Using WEMSA, we found that only one of the Sp-1-like binding sequences, located at position −91 to −79 (relative to the transcription start site), bound the transcription factor Sp1. Sp-1 binding to this site was demonstrable using nuclear extracts from control cells. Notably, binding activity was attenuated in nuclear extracts prepared from cells that had been incubated with calcitriol, thus suggesting Sp-1 involvement in calcitriol induction of CD14 expression. Notably, these results show that like EMSA, WEMSA can be broadly applied to aid in the identification of transcription factors involved in regulating gene expression. WEMSA, however, offers a number of distinct advantages when compared with conventional EMSA. Antibodies used for WEMSA often provide less ambiguous signals than those used in EMSA, and these do not have to recognize epitopes under native conditions. In addition, WEMSA does not require the use of labeled oligos, thus eliminating a significant expense associated with EMSA.Keywords
This publication has 10 references indexed in Scilit:
- 1α,25-Dihydroxycholecalciferol activates binding of CREB to a CRE site in theCD14promoter and drives promoter activity in a phosphatidylinositol-3 kinase-dependent mannerJournal of Leukocyte Biology, 2007
- Characterization of the human intestinal CD98 promoter and its regulation by interferon-γAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- Activating Transcription Factor/cAMP Response Element Binding Protein Family Member Regulated Transcription of CD1AThe Journal of Immunology, 2006
- Computational analysis of tissue-specific combinatorial gene regulation: predicting interaction between transcription factors in human tissuesNucleic Acids Research, 2006
- An ORFeome-based Analysis of Human Transcription Factor Genes and the Construction of a Microarray to Interrogate Their ExpressionGenome Research, 2004
- TRANSFAC(R): transcriptional regulation, from patterns to profilesNucleic Acids Research, 2003
- Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancerJournal of Cellular Physiology, 2001
- 1α,25-Dihydroxyvitamin D3–Induced Myeloid Cell Differentiation Is Regulated by a Vitamin D Receptor–Phosphatidylinositol 3-Kinase Signaling ComplexThe Journal of Experimental Medicine, 1999
- Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial CellsOnline Journal of Public Health Informatics, 1998
- Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.The Journal of Immunology, 1994